AI assistant
Banco Santander S.A. — Director's Dealing 2018
Dec 11, 2018
1798_dirs_2018-12-11_768c69c1-6fe3-420e-adb7-695194900b56.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 1497K
Banco Santander S.A.
11 December 2018
ANNEX
Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
THIS NOTIFICATION RELATES CRONJE, S.L.U.
2
Reason for the notification
a)
Position/status
tHIS notification RELATES TO CRONJE, S.L.U., personS closely associated with MS. ANA PATRICIA BOTIN-SANZ DE SAUTUOLA Y O´SHEA., CHAIRMAN OF THE ISSUER.
b)
Initial notification /Amendment
INITIAL NOTIFICATION
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
BANCO SANTANDER, S.A.
b)
LEI
5493006QMFDDMYWIAM13
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
ORDINARY SHARES OF 0.50 EURO NOMINAL VALUE (ISIN: ES0113900037)
b)
Nature of the transaction
PURCHASE.
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| 3.95 | 320,000 |
d)
Aggregated information
- Aggregated volume
- Price
ORDINARY SHARES OF 0.50 EURO NOMINAL VALUE (ISIN: ES0113900037):
| Price | Volume |
| 3.95 | 320,000 |
e)
Date of the transaction
2018-12-10
f)
Place of the transaction
XMAD
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHBUBDDLGBBGIB